Impaired awareness of hypoglycaemia: A new risk factor for adverse pregnancy outcomes in type 1 diabetes

被引:9
|
作者
Perea, Veronica [1 ]
Bertran, Berta [2 ]
Bellart, Jordi [3 ]
Orois, Aida [1 ,4 ]
Gimenez, Marga [4 ]
Conget, Ignacio [4 ]
Vinagre, Irene [4 ]
机构
[1] Hosp Univ Mutua Terrassa, Dept Endocrinol, 5 Doctor Robert Sq, Barcelona 08221, Spain
[2] Univ Barcelona, Univ Sch Nursing, Barcelona, Spain
[3] Hosp Clin Barcelona, Obstet & Gynecol Dept, Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Endocrinol, Diabet Unit, 170 Villarroel St, E-08036 Barcelona, Spain
关键词
impaired awareness of hypoglycaemia; pregnancy; type; 1; diabetes; PLASMA-LIPOPROTEINS; MOUSE EMBRYOS; WOMEN; PREECLAMPSIA; FETAL; INFLAMMATION; PREDICTORS; METABOLISM; INCREASES; RECOVERY;
D O I
10.1002/dmrr.3176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The aim of this study is to evaluate the impact of impaired awareness of hypoglycaemia (IAH) on metabolic control and pregnancy outcomes in women with type 1 diabetes. Material and Methods This was a single-centre prospective cohort study of singleton pregnant women with type 1 diabetes. IAH was assessed at the first antenatal visit using Clarke's test (score >= 3). Data on metabolic control, hypoglycaemic events, and the lipid profile were collected from prior to pregnancy and in each trimester of gestation. Pregnancy outcomes were also recorded. Results A total of 77 patients with type 1 diabetes were included; 24 (31.2%) were classified as having IAH. Compared with the normal awareness of hypoglycaemia (NAH) group, the IAH group did not show differences in HbA(1c), weight gain, insulin doses, or severe and nonsevere hypoglycaemia events throughout pregnancy. IAH was associated with higher triglyceride concentrations in the second trimester (IAH: 154.8 +/- 61.1 mg/dL, NAH: 128.6 +/- 31.2 mg/dL, P = .034) and an increased risk of neonatal respiratory distress (odds ratio [OR] 11.24; 95% CI, 1.01-124.9, P = .041) in adjusted models. Increased risk of pre-eclampsia was related to higher second trimester triglyceride concentrations (OR 1.028; 95% CI, 1.004-1.053, P = .023) adjusted for confounders. Conclusions The IAH was associated with increased risk of neonatal respiratory distress and pre-eclampsia, despite showing no differences in metabolic control. Hypoglycaemia awareness in the first antenatal visit should be assessed to identify the subgroup of pregnant women with increased risk of complications.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Residual C-peptide is associated with new and persistent impaired awareness of hypoglycaemia in type 1 diabetes
    Varkevisser, R. D. M.
    Sas, T.
    Aanstoot, H. J.
    Wolffenbuttel, B. H. R.
    van der Klauw, M. M.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (12)
  • [32] Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes
    Ali, Namam
    Janssen, Anna W. M.
    Jaeger, Martin
    Van de Wijer, Lisa
    van Der Heijden, Wouter
    ter Horst, Rob
    Vart, Priya
    van Gool, Alain
    Joosten, Leo A. B.
    Netea, Mihai G.
    Stienstra, Rinke
    De Galan, Bastiaan E.
    Tack, Cees J.
    DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2427 - 2436
  • [33] Cerebral blood flow response to hypoglycaemia is altered in patients with type 1 diabetes and impaired awareness of hypoglycaemia
    Wiegers, E. C.
    Becker, K. M.
    Rooijackers, H. M.
    von Samson-Himmelstjerna, F. C.
    Tack, C. J.
    Heerschap, A.
    van der Graaf', M.
    de Galan, B. E.
    DIABETOLOGIA, 2016, 59 : S42 - S42
  • [34] Impaired hypoglycaemia awareness in early pregnancy increases risk of severe hypoglycaemia in the mid-long term postpartum irrespective of breastfeeding status in women with type 1 diabetes
    Boswell, Laura
    Perea, Veronica
    Amor, Antonio J.
    Segui, Nuria
    Bellart, Jordi
    Roca, Daria
    Gimenez, Marga
    Conget, Ignacio
    Vinagre, Irene
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (01): : 18 - 26
  • [35] Impaired hypoglycaemia awareness in early pregnancy increases risk of severe hypoglycaemia in the mid-long term postpartum irrespective of breastfeeding status in women with type 1 diabetes
    Boswell, Laura
    Perea, Veronica
    Amor, Antonio J.
    Segui, Nuria
    Bellart, Jordi
    Roca, Daria
    Gimenez, Marga
    Conget, Ignacio
    Vinagre, Irene
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 : 18 - 26
  • [36] Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Ole Elvebakk
    Christian Tronstad
    Kåre I. Birkeland
    Trond G. Jenssen
    Marit R. Bjørgaas
    Kathrine F. Frøslie
    Kristin Godang
    Håvard Kalvøy
    Ørjan G. Martinsen
    Hanne L. Gulseth
    Scientific Reports, 8
  • [37] Cardiac autonomic regulation during experimental hypoglycaemia in Type 1 diabetes with impaired awareness of hypoglycaemia (IAH)
    Walkinshaw, E.
    Little, S. A.
    Bernjak, A.
    Lubina-Solomon, A.
    Chow, E.
    Shaw, J. A.
    Heller, S. R.
    DIABETIC MEDICINE, 2015, 32 : 61 - 61
  • [38] Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Elvebakk, Ole
    Tronstad, Christian
    Birkeland, Kare I.
    Jenssen, Trond G.
    Bjorgaas, Marit R.
    Froslie, Kathrine F.
    Godang, Kristin
    Kalvoy, Havard
    Martinsen, Orjan G.
    Gulseth, Hanne L.
    SCIENTIFIC REPORTS, 2018, 8
  • [39] Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on inflammatory profile in people with type 1 diabetes
    Ali, N.
    Janssen, A. W. M.
    De Galan, B. E.
    Tack, C. J.
    Jaeger, M.
    Van de Wijer, L.
    van der Heijden, W.
    ter Horst, R.
    Vart, P.
    van Gool, A.
    Joosten, L. A. B.
    Netea, M. G.
    Stienstra, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S96 - S96
  • [40] RESTORING IMPAIRED AWARENESS OF HYPOGLYCAEMIA IN TYPE 1 DIABETES THROUGH TECHNOLOGY: A SYSTEMATIC REVIEW
    Yeoh, E. C. K.
    Nwokolo, M.
    Amiel, S. A.
    Choudhary, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A166 - A167